– May 21-23, 2026 | Warsaw, Poland –
Zy Therapeutics will be attending the International Conference on Tuberous Sclerosis Complex and Related Neurocutaneous Disorders in Warsaw, where the team will highlight ongoing work to advance KaminiTM as a potential disease-modifying approach targeting pathological calcium accumulation in the central nervous system, with relevance for TSC and related neurocutaneous disorders, including Sturge–Weber Syndrome.
As always, we look forward to connecting with clinicians, researchers, collaborators, and potential partners who share our commitment to advancing treatment innovation in rare neurological disease.
For more information on the conference, please visit:
https://tsc.viamedica.pl/51810.1.2026.warszawa
